Intended Use
This kit is intended for use as a point-of-care test to quantitatively measure the content of gastrin 17 (G-17) in human samples (serum and plasma) in vitro. Clinically, the test is suitable for the auxiliary diagnosis of atrophic gastritis, peptic ulcer and other diseases, but not for the auxiliary diagnosis of gastric cancer.